New cost for AIDS drug: $30600 a year Consumer

Sales of Trimeris" AIDS drug Fuzeon might on the decline, but the cost is on the rise.

The Durham association disclosed in a filing with the Securities and Exchange Commission this week that the indiscriminate cost of a one-year supply of Fuzeon has been increasing by 3 percent. The new price: $30,600.

Trimeris remarkable that the Swiss curative hulk Roche, that markets the drug, has solitary shortcoming for environment the price.

The new cost is 50 percent higher than the cost of a years supply for Fuzeon when it was launched in 2003.

Fuzeon sales have been shrinking since of the high price, the side goods and the accessibility of newer drugs.

For all of 2009, Fuzeon sales totaled $112.2 million, down 33 percent from 2008. Trimeris receives kingship fees on the sales of the drug, that is the companys usually product.